Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study

Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study

(2017) George Grunberger et al.   Diabetes Therapy

Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study

(2017) George Grunberger et al.   Diabetes Therapy

Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review

(2016) Sanjay Kalra et al.   ADVANCES IN THERAPY

Hypoglycaemia when adding sulphonylurea to metformin: a systematic review and network meta-analysis

(2016) Stig Ejdrup Andersen et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Introduction

(2016)   DIABETES CARE

Update on developments with SGLT2 inhibitors in the management of type 2 diabetes

(2014) Michael Nauck   Drug Design Development and Therapy

Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial

(2014) Martin Ridderstråle et al.   Lancet Diabetes & Endocrinology

Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

(2013) William T Cefalu et al.   LANCET

Glycaemic control and adverse events in patients with type 2 diabetes treated with metformin + sulphonylurea: a meta-analysis

(2008) J. Belsey et al.   DIABETES OBESITY & METABOLISM

Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus

(2008) Manuel González-Ortiz et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS